What is Celebrex?
Celebrex is the brand name for celecoxib, a non-steroidal antiinflammatory used to relieve the pain, swelling and stiffness of osteoarthritis and adult rheumatoid arthritis; to treat of primary dysmenorrhea; and to reduce intestinal polyps in the inherited disorder adenomatous polyposis.
Reasons taken & Efficacy
| Reasons taken | # of patients | Major | Moderate | Slight | None | Can’t tell | # of patients evaluated by |
|---|---|---|---|---|---|---|---|
| Pain | 32 |
|
|
|
|
7 | |
| Other | 14 |
|
|
|
6 | ||
| Arthritis | 10 |
|
|
2 | |||
| Stiffness/Spasticity | 8 |
|
|
2 | |||
| General health | 4 | 0 | |||||
| Inflammation | 4 |
|
|
2 |
See all 60 patients currently taking Celebrex
Mouse over the table for more information
Side Effects
Dosages
Stop Reasons
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
|
Did not seem to work
|
8 | 32% |
|
|
Side effects too severe
|
6 | 24% |
|
|
Expense
|
3 | 12% |
|
|
Doctor's advice
|
3 | 12% |
|
|
Other
|
3 | 12% |
|
|
Course of treatment ended
|
3 | 12% |
|
Adherence, Burden & Cost See details from patient evaluations ▼
See more information, including instructions, precautions, side effects, and interactions.
Patient Evaluations
See all 16 patient evaluations
-
- chris001
- Sex: F
- Sensation: Mild
- Overall: Mild
- Cognition: mild
- Vision: mild
- Speech: mild
- Swallowing: moderate
- Upper limb: mild
- Walking: none
- See profile
-
- chris001
- 200 mg daily
- since Sep 14, 2008
-
Efficacy
Moderate
for Stiffness/Spasticity
-
Side Effects
None
- See full evaluation
-
- katpalou
- Sex: F
- Sensation: Moderate
- Overall: Mild
- Cognition: moderate
- Vision: moderate
- Speech: moderate
- Swallowing: moderate
- Upper limb: none
- Walking: mild
- See profile
-
-
- katpalou
- 100 mg daily
- since Dec 13, 2008
-
Efficacy
None
for Pain
-
Side Effects
Severe
- See full evaluation
-
- babsinfisk
- Sex: F
- Sensation: Moderate
- Overall: Moderate
- Cognition: moderate
- Vision: moderate
- Speech: moderate
- Swallowing: moderate
- Upper limb: moderate
- Walking: moderate
- See profile
-
-
- babsinfisk
- 400 mg daily
- since Feb 01, 2009
-
Efficacy
Major
for Other
-
Side Effects
None
- See full evaluation
See all 16 patient evaluations
Report created on November 24, 2009.